PNC Financial Services Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.88M | Buy |
41,119
+1,635
| +4% | +$313K | ﹤0.01% | 596 |
|
|
2026
Q1 | $7.24M | Buy |
39,484
+766
| +2% | +$141K | ﹤0.01% | 631 |
|
|
2025
Q4 | $6.81M | Sell |
38,718
-984
| -2% | -$161K | ﹤0.01% | 628 |
|
|
2025
Q3 | $5.56M | Buy |
39,702
+1,613
| +4% | +$218K | ﹤0.01% | 679 |
|
|
2025
Q2 | $4.78M | Buy |
38,089
+12,894
| +51% | +$1.61M | ﹤0.01% | 699 |
|
|
2025
Q1 | $3.45M | Buy |
25,195
+21
| +0.1% | +$3K | ﹤0.01% | 758 |
|
|
2024
Q4 | $3.85M | Buy |
25,174
+1,753
| +7% | +$296K | ﹤0.01% | 722 |
|
|
2024
Q3 | $4.54M | Sell |
23,421
-1,173
| -5% | -$245K | ﹤0.01% | 687 |
|
|
2024
Q2 | $5.7M | Buy |
24,594
+9
| +0% | +$1.96K | ﹤0.01% | 607 |
|
|
2024
Q1 | $5.3M | Buy |
24,585
+218
| +0.9% | +$51.1K | ﹤0.01% | 635 |
|
|
2023
Q4 | $6.31M | Sell |
24,367
-746
| -3% | -$183K | 0.01% | 586 |
|
|
2023
Q3 | $6.45M | Sell |
25,113
-2,424
| -9% | -$648K | 0.01% | 563 |
|
|
2023
Q2 | $7.84M | Sell |
27,537
-704
| -2% | -$210K | 0.01% | 539 |
|
|
2023
Q1 | $7.85M | Sell |
28,241
-417
| -1% | -$115K | 0.01% | 534 |
|
|
2022
Q4 | $7.94M | Sell |
28,658
-268
| -0.9% | -$75.7K | 0.01% | 530 |
|
|
2022
Q3 | $7.72M | Sell |
28,926
-449
| -2% | -$95.4K | 0.01% | 525 |
|
|
2022
Q2 | $5.99M | Sell |
29,375
-5,409
| -16% | -$1.11M | 0.01% | 588 |
|
|
2022
Q1 | $7.33M | Sell |
34,784
-6,048
| -15% | -$1.32M | 0.01% | 592 |
|
|
2021
Q4 | $9.8M | Sell |
40,832
-5,533
| -12% | -$1.42M | 0.01% | 537 |
|
|
2021
Q3 | $13.1M | Sell |
46,365
-2,861
| -6% | -$938K | 0.01% | 467 |
|
|
2021
Q2 | $17M | Sell |
49,226
-9,395
| -16% | -$2.85M | 0.02% | 420 |
|
|
2021
Q1 | $16.4M | Sell |
58,621
-6,072
| -9% | -$1.64M | 0.02% | 412 |
|
|
2020
Q4 | $15.8M | Sell |
64,693
-6,841
| -10% | -$1.76M | 0.02% | 403 |
|
|
2020
Q3 | $20.3M | Sell |
71,534
-4,839
| -6% | -$1.35M | 0.03% | 350 |
|
|
2020
Q2 | $20.4M | Sell |
76,373
-5,845
| -7% | -$1.76M | 0.03% | 334 |
|
|
2020
Q1 | $26M | Buy |
82,218
+3,264
| +4% | +$991K | 0.03% | 289 |
|
|
2019
Q4 | $23.4M | Sell |
78,954
-15,587
| -16% | -$4.32M | 0.02% | 333 |
|
|
2019
Q3 | $22M | Sell |
94,541
-2,932
| -3% | -$683K | 0.02% | 337 |
|
|
2019
Q2 | $22.8M | Sell |
97,473
-38,312
| -28% | -$8.85M | 0.02% | 348 |
|
|
2019
Q1 | $32.1M | Sell |
135,785
-236,739
| -64% | -$74.5M | 0.03% | 312 |
|
|
2018
Q4 | $112M | Sell |
372,524
-1,862
| -0.5% | -$594K | 0.12% | 142 |
|
|
2018
Q3 | $132M | Sell |
374,386
-5,508
| -1% | -$1.9M | 0.13% | 141 |
|
|
2018
Q2 | $110M | Sell |
379,894
-15,649
| -4% | -$4.4M | 0.11% | 157 |
|
|
2018
Q1 | $108M | Sell |
395,543
-20,522
| -5% | -$6.37M | 0.11% | 159 |
|
|
2017
Q4 | $133M | Sell |
416,065
-14,499
| -3% | -$4.65M | 0.13% | 141 |
|
|
2017
Q3 | $135M | Sell |
430,564
-4,445
| -1% | -$1.32M | 0.14% | 134 |
|
|
2017
Q2 | $118M | Sell |
435,009
-11,401
| -3% | -$3.01M | 0.13% | 148 |
|
|
2017
Q1 | $122M | Buy |
446,410
+102,132
| +30% | +$28.9M | 0.14% | 147 |
|
|
2016
Q4 | $97.6M | Sell |
344,278
-9,320
| -3% | -$2.76M | 0.11% | 163 |
|
|
2016
Q3 | $111M | Buy |
353,598
+251,463
| +246% | +$74.5M | 0.13% | 143 |
|
|
2016
Q2 | $24.7M | Buy |
102,135
+23,533
| +30% | +$6.2M | 0.03% | 352 |
|
|
2016
Q1 | $20.5M | Sell |
78,602
-2,123
| -3% | -$561K | 0.02% | 376 |
|
|
2015
Q4 | $24.7M | Sell |
80,725
-24,108
| -23% | -$6.93M | 0.03% | 333 |
|
|
2015
Q3 | $30.6M | Sell |
104,833
-37,865
| -27% | -$12.5M | 0.04% | 307 |
|
|
2015
Q2 | $57.6M | Buy |
142,698
+16,903
| +13% | +$6.78M | 0.06% | 222 |
|
|
2015
Q1 | $53.1M | Buy |
125,795
+21,271
| +20% | +$8.38M | 0.06% | 232 |
|
|
2014
Q4 | $35.5M | Buy |
104,524
+14,786
| +16% | +$4.78M | 0.04% | 282 |
|
|
2014
Q3 | $29.7M | Buy |
89,738
+7,138
| +9% | +$2.35M | 0.04% | 297 |
|
|
2014
Q2 | $26M | Buy |
82,600
+2,379
| +3% | +$716K | 0.03% | 304 |
|
|
2014
Q1 | $24.5M | Buy |
80,221
+2,100
| +3% | +$667K | 0.03% | 300 |
|
|
2013
Q4 | $21.8M | Buy |
78,121
+4,072
| +5% | +$1.05M | 0.03% | 322 |
|
|
2013
Q3 | $17.8M | Buy |
74,049
+5,214
| +8% | +$1.17M | 0.03% | 351 |
|
|
2013
Q2 | $14.8M | Buy |
+68,835
| New | +$14.7M | 0.02% | 360 |
|
Other funds holding BIIB
AIM
PNC Financial Services Group's BIIB Position: Q2 2026 in Review
PNC Financial Services Group increased its Biogen (BIIB) stake by 4.1% in Q2 2026, buying an estimated $313K and bringing the position to 41,119 shares worth $8.88M. The position accounts for ﹤0.01% of the portfolio, ranked #596.
PNC Financial Services Group first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $135M in Q3 2017. 569 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- PNC Financial Services Group held 41,119 shares of Biogen worth $8.88M as of Q2 2026.
- PNC Financial Services Group bought 1,635 Biogen shares in Q2 2026, an estimated $313K.
- Biogen made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #596 holding.
- PNC Financial Services Group first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
- PNC Financial Services Group's Biogen position peaked at $135M in Q3 2017.
- 569 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.